Pressemitteilungen

Varian Expects to Benefit from Linear Accelerator Tariff Exclusion in China

Varian (NYSE: VAR) has received notice from the Customs Tariff Commission of the State Council of China that medical linear accelerators are excluded from the additional tariffs China imposed on...

Varian-equipped New York Proton Therapy Center Treats First Patients

The New York Proton Center (NYPC) has treated its first proton therapy cancer patients. Equipped with the Varian ProBeam® proton therapy system, NYPC is New York State's first proton therapy...

Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at Sylvester Comprehensive Cancer Center

Varian (NYSE: VAR) has completed the installation of the cyclotron for its ProBeam® Compact single-room proton therapy system at Sylvester Comprehensive Cancer Center at the University of Miami...

Varian Completes Purchase of Embolic Bead Asset

Varian (NYSE: VAR) today announced it has successfully completed its asset purchase of the Boston Scientific portfolio of microsphere and bland embolic bead products for treating...

Dr. Phil Febbo Named to Varian Board of Directors

Varian (NYSE: VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at Illumina has been appointed to the Varian Board of Directors, effective August 16, 2019. "We are proud to...

Varian to Hold Investor Day in New York City

Varian (NYSE: VAR) today announced that its executive management team will be hosting an Investor Day on Friday, November 15, 2019 at The Plaza Hotel, Fifth Avenue at Central Park South, New York,...

Varian Updates Investors on Proposed Reimbursement Changes

This afternoon, Varian (NYSE: VAR) posted a presentation providing an overview of the recently proposed radiation oncology alternative payment model and calendar year 2020 rates by the Center for...

Varian to Host Investor Meeting at ASTRO in Chicago

Varian (NYSE: VAR) today announced that its executive staff will be meeting with analysts and investors at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago on Monday,...

Varian Announces Immaterial Impact of Newly Proposed Tariffs

Varian (NYSE: VAR) today announced that the newly proposed tariffs by the U.S. on the remaining $300 billion of Chinese imports should have no material impact to the company. Last Thursday, the...

Three Radiotherapy Centers in Serbia Standardize on Varian Solution for Cancer Treatment Planning

Following a public competitive review process, Varian (NYSE: VAR) was selected to supply its Eclipse™ treatment planning software and ARIA® oncology information system to three radiotherapy...